What you do in ventricular tachycardia depends entirely on one question: does the person have a pulse? Pulseless vtach is treated the same as cardiac arrest, with CPR and defibrillation. Vtach with a pulse splits into two paths based on whether the person is hemodynamically stable or showing signs of collapse. Every decision flows from that initial assessment.
Pulseless Vtach: Treat It Like Cardiac Arrest
If someone is unconscious, not breathing, and has no pulse, pulseless vtach is functionally identical to ventricular fibrillation. The heart is firing so fast it can’t pump blood. The response is immediate and aggressive.
For bystanders, the sequence is straightforward. Call 911 first. Begin chest compressions immediately, pushing hard and fast in the center of the chest. If an AED (automated external defibrillator) is available, turn it on and follow the voice prompts. Remove any clothing covering the chest so the pads stick directly to skin. Body hair may need to be quickly shaved if it prevents good contact. The AED analyzes the heart rhythm on its own and will only deliver a shock if it detects a rhythm that responds to defibrillation, which includes pulseless vtach. Don’t touch the person while the device is analyzing. Continue CPR between shocks until paramedics arrive.
In a clinical setting, the protocol calls for unsynchronized defibrillation, high-quality CPR, and IV medications. After initial defibrillation, if the rhythm persists, epinephrine is given every few minutes. An antiarrhythmic is added next. In cardiac arrest specifically, the first dose is 300 mg IV push, with a follow-up dose of 150 mg if the rhythm doesn’t convert after five minutes.
Unstable Vtach With a Pulse
A person in vtach who still has a pulse but is deteriorating needs synchronized cardioversion. “Unstable” means the fast heart rate is causing dangerous symptoms: a drop in blood pressure, chest pain, shortness of breath, altered consciousness, or signs of shock. These are signals that the heart can’t keep up with the body’s demand for blood, and the rhythm needs to be corrected immediately.
Synchronized cardioversion delivers a controlled electrical shock timed to a specific point in the heart’s electrical cycle. This is different from defibrillation, which delivers energy at any point. The synchronization reduces the risk of pushing the heart into an even more dangerous rhythm. Sedation is given first if the patient is conscious. The key principle here: don’t delay cardioversion to start medications. Electricity is faster and more reliable when someone is crashing.
Stable Vtach With a Pulse
Some people tolerate vtach surprisingly well. They’re alert, their blood pressure is adequate, and they aren’t showing signs of organ compromise. This is stable vtach, and it buys time for a more measured approach.
The first-line treatment is typically an IV antiarrhythmic to slow the heart and restore a normal rhythm. The infusion runs over 10 minutes or longer, not as a rapid push, because the goal is chemical conversion without destabilizing the patient further. Throughout this process, the patient is monitored continuously. If at any point they become unstable (dropping blood pressure, losing consciousness, developing chest pain), the plan shifts immediately to synchronized cardioversion.
Stable vtach can look deceptively calm. The rhythm is still dangerous and can degrade into pulseless vtach or ventricular fibrillation without warning. Continuous monitoring and having a defibrillator at the bedside is non-negotiable.
How to Recognize Vtach
Ventricular tachycardia is a fast heart rhythm originating in the lower chambers of the heart, typically running at 100 to 250 beats per minute. On a heart monitor or ECG, the defining feature is a wide QRS complex, meaning the electrical signal is taking an abnormal path through the ventricles rather than following the heart’s normal wiring.
Vtach comes in two main varieties. Monomorphic vtach shows a consistent, repeating pattern on the monitor, with each beat looking like the last. Polymorphic vtach has a shifting, irregular appearance and is generally more unstable. It’s also classified by duration: non-sustained vtach lasts less than 30 seconds and stops on its own, while sustained vtach persists and almost always requires intervention.
One common clinical challenge is telling vtach apart from a supraventricular tachycardia (SVT) with aberrant conduction, which can look similar on a monitor. Multiple ECG leads are needed to check for specific clues like the presence of independent atrial activity, the electrical axis of the heart, and the shape of the QRS complex. The practical rule in an emergency: if you’re not sure whether it’s vtach or SVT, treat it as vtach. That approach is safer.
What Symptoms Feel Like
People in vtach often feel a sudden, pounding heart rate. When the rhythm prevents the heart from filling properly between beats, blood output drops and symptoms escalate. Lightheadedness and shortness of breath come first. Some people feel pressure or pain in the chest. As the heart’s pumping efficiency falls further, fainting or loss of consciousness can follow. In sustained vtach, the progression from “I feel off” to unconsciousness can happen in seconds to minutes.
Common Triggers and Causes
Vtach rarely happens in a completely healthy heart. The most common underlying cause is damage from a prior heart attack, which creates areas of scarred tissue that disrupt normal electrical conduction. Other structural heart conditions, including cardiomyopathy (weakened heart muscle), also set the stage.
Electrolyte imbalances are a major and correctable trigger. In the LYTE-VT study, 35.7% of patients presenting with ventricular arrhythmias had low potassium levels, compared to just 12.9% of heart failure patients without arrhythmias. Severely low potassium (below 3.0 mmol/L) was found in 13.6% of the arrhythmia group. Magnesium deficiency also plays a role, though it showed up less frequently at around 7.8%. This is why checking and correcting electrolytes is one of the first things done alongside rhythm management. If low potassium triggered the episode, no amount of antiarrhythmic medication will prevent it from happening again until the potassium is replaced.
Long-Term Management After an Episode
Surviving a vtach episode opens a conversation about prevention. The two main long-term strategies are implantable defibrillators and catheter ablation, sometimes used together.
Implantable Cardioverter-Defibrillators (ICDs)
An ICD is a small device implanted under the skin near the collarbone that continuously monitors heart rhythm. If it detects vtach or ventricular fibrillation, it delivers a shock internally to restore normal rhythm. ICDs are recommended for people with significantly reduced heart function (typically an ejection fraction of 35% or less) or those who’ve survived a sustained vtach episode. In a large trial of heart failure patients who received ICDs, 16.4% died within five years of follow-up, meaning the device helped the majority survive a period when they were at high risk for fatal arrhythmias.
Catheter Ablation
For recurrent vtach, catheter ablation targets the specific areas of heart tissue generating the abnormal electrical signals. A thin catheter is threaded through a blood vessel to the heart, and energy is applied to destroy the problem tissue. About 52% of patients remain free of vtach recurrence at three years after ablation, according to registry data. Success rates are better for people whose heart disease is not caused by prior heart attacks (61% free of recurrence) compared to those with ischemic damage (45%). Complication rates range from 6% to 15% across studies, which includes risks like bleeding, blood vessel damage, or fluid accumulation around the heart.
Neither option is a cure in isolation. ICDs don’t prevent vtach; they terminate it after it starts. Ablation reduces episodes but has a meaningful recurrence rate. Most patients with recurrent vtach end up on some combination of an ICD, medications, and possibly ablation, tailored to how often episodes happen and how well they tolerate them.